These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36437154)

  • 1. Pharmacist biosimilar survey reveals knowledge gaps.
    Stevenson JG; McCabe D; McGrath M; McBride A
    J Am Pharm Assoc (2003); 2023; 63(2):529-537.e7. PubMed ID: 36437154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for Overcoming Barriers to Adopting Biosimilars and Achieving Goals of the Biologics Price Competition and Innovation Act: A Survey of Managed Care and Specialty Pharmacy Professionals.
    Greene L; Singh RM; Carden MJ; Pardo CO; Lichtenstein GR
    J Manag Care Spec Pharm; 2019 Aug; 25(8):904-912. PubMed ID: 31007119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of pharmacists' views on biosimilar naming conventions.
    Fernandez-Lopez S; Kazzaz D; Bashir M; McLaughlin T
    J Manag Care Spec Pharm; 2015 Mar; 21(3):188-95. PubMed ID: 25726028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosimilar Naming Conventions: Pharmacist Perceptions and Impact on Confidence in Dispensing Biologics.
    Tomaszewski D
    J Manag Care Spec Pharm; 2016 Aug; 22(8):919-26. PubMed ID: 27459654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosimilar perceptions among autoimmune prescribers and pharmacists in health system specialty pharmacy.
    Giavatto C; Mourani J; Fitzpatrick C; Hardin B; Skrtic A; Evans A; Sredzinski E; Trieu S; Setter AI; Kobiska L; Lopez-Medina AI
    J Manag Care Spec Pharm; 2024 Feb; 30(2):175-182. PubMed ID: 38308629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of global biosimilar implementation practice conducted by the International Society of Oncology Pharmacy Practitioners.
    Foreman E; Patel H; Siderov J; Harchowal J; Bubalo J; Chan A
    J Oncol Pharm Pract; 2020 Apr; 26(3_suppl):22-32. PubMed ID: 32268828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians.
    Barbier L; Vandenplas Y; Simoens S; Declerck P; Vulto AG; Huys I
    J Pharm Policy Pract; 2021 Jun; 14(1):53. PubMed ID: 34158128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The growing role of biologics and biosimilars in the United States: Perspectives from the APhA Biologics and Biosimilars Stakeholder Conference.
    Crespi-Lofton J; Skelton JB
    J Am Pharm Assoc (2003); 2017; 57(5):e15-e27. PubMed ID: 28689708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malaysian Hospital Pharmacists' Perspectives and Their Role in Promoting Biosimilar Prescribing: A Nationwide Survey.
    Mohd Sani N; Aziz Z; Kamarulzaman A
    BioDrugs; 2023 Jan; 37(1):109-120. PubMed ID: 36571697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacists' Perspectives of Biosimilars: A Systematic Review.
    Mohd Sani N; Aziz Z; Panickar R; Kamarulzaman A
    BioDrugs; 2022 Jul; 36(4):489-508. PubMed ID: 35776294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives of Hospital Pharmacists Towards Biosimilar Medicines: A Survey of Polish Pharmacy Practice in General Hospitals.
    Pawłowska I; Pawłowski L; Krzyżaniak N; Kocić I
    BioDrugs; 2019 Apr; 33(2):183-191. PubMed ID: 30830647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing biosimilar education needs among oncology pharmacy practitioners worldwide: An ISOPP membership survey.
    Chan A; Patel H; Siderov J; Bubalo J; Foreman E
    J Oncol Pharm Pract; 2020 Apr; 26(3_suppl):11-21. PubMed ID: 32268832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. US rheumatologists' beliefs and knowledge about biosimilars: a survey.
    Gibofsky A; McCabe D
    Rheumatology (Oxford); 2021 Feb; 60(2):896-901. PubMed ID: 33146388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge, perceptions, attitude, barriers and facilitators of biosimilars use across specialty physicians and hospital pharmacists: A national survey.
    Marín-Jiménez I; Carrascosa JM; Guigini MA; Monte-Boquet E
    Farm Hosp; 2021 Jul; 45(5):240-246. PubMed ID: 34806583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparing for the market entry of adalimumab biosimilars in the US in 2023: A primer for specialty pharmacists.
    Cisek S; Choi D; Stubbings J; Bhat S
    Am J Health Syst Pharm; 2023 Sep; 80(18):1223-1233. PubMed ID: 37257054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge, behaviors and practices of community and hospital pharmacists towards biosimilar medicines: Results of a French web-based survey.
    Beck M; Michel B; Rybarczyk-Vigouret MC; Levêque D; Sordet C; Sibilia J; Velten M
    MAbs; 2017; 9(2):383-390. PubMed ID: 27929743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Awareness and Knowledge of Pharmacists toward Biosimilar Medicines: A Survey in Jordan.
    Oqal M; Hijazi B; Alqudah A; Al-Smadi A; A Almomani B; Alnajjar R; Abu Ghunaim M; Irshaid M; Husam A
    Int J Clin Pract; 2022; 2022():8080308. PubMed ID: 35832802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacist perspectives and considerations for implementation of therapeutic oncology biosimilars in practice.
    Cuellar S; McBride A; Medina P
    Am J Health Syst Pharm; 2019 Oct; 76(21):1725-1738. PubMed ID: 31612935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A survey of pharmacists' knowledge and views of biosimilars in Quebec and France.
    Adé A; Bourdon O; Bussières JF
    Ann Pharm Fr; 2017 Jul; 75(4):267-275. PubMed ID: 28237527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Framework for Integrating Biosimilars Into the Didactic Core Requirements of a Doctor of Pharmacy Curriculum.
    Li E; Liu J; Ramchandani M
    Am J Pharm Educ; 2017 Apr; 81(3):57. PubMed ID: 28496277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.